Oct 29, 2017 Law 360 Interview with Teva General Counsel David Stark To read the full article click here
Jul 9, 2017 Teva Recognized With a 2017 Korn Ferry Employee Engagement Award Teva has been awarded a Korn Ferry Employee Engagement Award, recognizing a best-in-class level of engagement in France, Mexico and Poland.
Jun 29, 2017 Teva unveils new data and expert insights on the emerging public health issue of multiple chronic conditions during the week of 70th World Health Assembly Data presented during the week of 70th World Health Assembly, in Geneva, placed a spotlight on an emerging global public healthcare challenge – the growing burden of managing multiple chronic conditions. The data, presented to a group of renowned public healthcare experts, convened by the International Association of Patient Organizations (IAPO) and Teva, showed a worrying gap in understanding and planning of the management of patients diagnosed with multiple chronic conditions (polychronic).
Jun 28, 2017 Healthcare Heroes Awards Program to Honor Former Teva Executive On June 13th, the National Liberty Museum in Philadelphia hosted an event honoring Richard Egosi, former Teva group EVP and chief legal officer, who passed away in 2016. Friends, family and colleagues gathered to remember Rich and to celebrate the kick off of the Healthcare Heroes Awards program, being sponsored by Teva in his memory.
May 5, 2017 Ukrainian Prime Minister Visits Teva Ukrainian Prime Minister Volodymyr Groysman recently visited Teva as part of an official visit to Israel.
Nov 1, 2016 Big Win for Teva's Eva Kopecna Teva's Eva Kopecna wins Contribution award at the Organization for Professionals in Regulatory Affairs (TOPRA) Awards. Teva sponsors one category and wins in another.
May 1, 2016 Croatian Prime Minister Orešković Opens Teva’s Multi-purpose Synthesis Plant in Croatia The opening of the new multi-purpose synthesis plant at Teva’s Croatian site in Savski Marof marks the end of the greatest investment cycle in PLIVA’s history, worth over one billion kuna. The new plant, worth half a billion kuna, will double production capacities in some segments at Savski Marof. More than 95 % of products will be exported to the largest markets around the word.
Dec 8, 2015 Beyond the Pill: IT Leads Teva’s Technology Revolution Pharma Tech Outlook Magazine, an authoritative journal for technological biopharmaceutical developments, published a special edition editorial featuring Guy Hadari, SVP & CIO, Teva Pharmaceuticals.
Dec 8, 2015 Teva Opts for 100% Renewable Energy in Germany Teva's German production sites are planning to convert their electricity supplies to 100% renewable energy. By December 2015, they will be using only “green energy”.
Nov 5, 2015 Anna Yarvits Among Russia's 25 Most Influential Women CEOs! In a remarkable achievement, Anna Yarvits, SVP General Manager, Teva Russia & CIS, has been rated as one of the 25 Most Influential Women CEO in Russian Business.
May 1, 2015 Teva Helps the Victims of the Nepal Earthquake On April 25, a devastating earthquake of 7.9 magnitude hit Nepal and the surrounding areas.
Apr 15, 2015 Teva's Dedication and Commitment Recognized by Patients Fourth annual PatientView survey identifies Teva as a “Corporate Star” in the eyes of patients. Making medicines accessible is key to patient groups.
Apr 15, 2015 New Partnership to Improve Care for Multiple Chronic Conditions (MCC) Teva, the world’s largest generic drug company, and Mount Sinai Health System, one of the largest hospital groups in the United States announced a partnership to improve patient and health system care for Multiple Chronic Conditions.